Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 4.710
-0.100 (-2.08%)
Jun 18, 2026, 10:14 AM HKT
Jiangsu Recbio Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -610.39 | -562.39 | -571.96 | -722.7 | -657.56 |
Depreciation & Amortization | 119.36 | 78.83 | 59.91 | 40.88 | 22.46 |
Other Amortization | 5.06 | 5.41 | 4.45 | 0.38 | - |
Loss (Gain) From Sale of Assets | 0.11 | -0.06 | -6.57 | 0.09 | 0.02 |
Asset Writedown & Restructuring Costs | - | 3.86 | - | - | - |
Loss (Gain) From Sale of Investments | -1.59 | -0.09 | -0.49 | -3.56 | -11.22 |
Stock-Based Compensation | 30.18 | 33.66 | 41.89 | 47.82 | 137.69 |
Other Operating Activities | 23.82 | 4.13 | -39.94 | -145.73 | 54.44 |
Change in Inventory | 19.32 | -53.87 | -45.63 | -32.61 | -15.79 |
Change in Accounts Payable | -43.49 | -55.29 | 52.56 | 45.7 | 14.83 |
Change in Unearned Revenue | -11.3 | -16.91 | 14.67 | 28.9 | 14.12 |
Change in Other Net Operating Assets | -33.72 | 97.91 | -146.97 | 161.28 | -31.91 |
Operating Cash Flow | -502.64 | -464.83 | -638.07 | -579.54 | -472.92 |
Capital Expenditures | -98.86 | -171.83 | -212.04 | -296.73 | -237.87 |
Sale of Property, Plant & Equipment | 0.62 | 0.59 | - | - | - |
Sale (Purchase) of Intangibles | - | - | -12.07 | -11.77 | - |
Investment in Securities | 129.28 | -129.28 | 187.46 | -97.46 | 285 |
Other Investing Activities | 4.39 | 21.47 | 46.07 | 27.53 | 21.57 |
Investing Cash Flow | 35.43 | -279.04 | 9.42 | -378.43 | 68.7 |
Long-Term Debt Issued | 471.62 | 305.24 | 408.87 | 183.52 | 50 |
Long-Term Debt Repaid | -739.31 | -71.01 | -20.77 | -10.95 | -6.42 |
Net Debt Issued (Repaid) | -267.7 | 234.23 | 388.1 | 172.57 | 43.58 |
Issuance of Common Stock | 789.99 | - | - | 669.71 | 1,194 |
Repurchase of Common Stock | - | - | -100 | - | - |
Other Financing Activities | -22.52 | -16.18 | -12.83 | -2.84 | -8.18 |
Financing Cash Flow | 499.77 | 218.06 | 275.28 | 839.44 | 1,229 |
Foreign Exchange Rate Adjustments | 0.24 | 9.87 | 19.26 | 115.06 | -8.49 |
Net Cash Flow | 32.8 | -515.94 | -334.11 | -3.47 | 816.74 |
Free Cash Flow | -601.5 | -636.66 | -850.11 | -876.27 | -710.79 |
Free Cash Flow Margin | -4726.54% | - | -2798.55% | -16455.78% | -11466.17% |
Free Cash Flow Per Share | -1.13 | -1.33 | -1.77 | -1.85 | -1.69 |
Cash Interest Paid | 20.12 | 14.68 | 10.43 | 1.62 | - |
Cash Income Tax Paid | 2.16 | - | - | - | - |
Levered Free Cash Flow | -367.78 | -407.19 | -637.15 | -574.61 | -502.59 |
Unlevered Free Cash Flow | -352.81 | -395.38 | -628.67 | -572.41 | -467.4 |
Change in Working Capital | -69.19 | -28.16 | -125.37 | 203.27 | -18.75 |